Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
36.2%
% of CANC's 47 holdings also in BBC
16.5%
% of BBC's 122 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus BBC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBC |
Overlap | |
|---|---|---|---|---|
 |
NURIX THERAPEUTICS, INC. | 0.9% | 1.0% | 0.9% |
|
CELLDEX THERAPEUTICS INC | 1.5% | 0.9% | 0.9% |
|
REVOLUTION MEDICINES, INC. | 4.6% | 0.9% | 0.9% |
|
ARCELLX, INC. | 1.6% | 0.9% | 0.9% |
|
ORIC PHARMACEUTICALS INC | 0.8% | 1.2% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBC
|
GILEAD SCIENCES INC | 5.4% |
|
REGENERON PHARMACEUTICALS | 5.4% |
 |
ASTRAZENECA PLC | 5.2% |
|
BLUEPRINT MEDICINES CORP. | 4.3% |
 |
ARGENX SE ADR | 4.3% |
|
INCYTE CORP | 4.2% |
|
ILLUMINA INC | 3.8% |
|
REVOLUTION MEDICINES, INC. | 3.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.3% |
|
DAIICHI SANKYO CO LTD | 3.1% |
CANC Underweight Relative to BBC
|
MORPHIC HOLDING, INC. | -1.5% |
|
LONGBOARD PHARMACEUTICALS, INC. | -1.4% |
|
ACELYRIN, INC. | -1.2% |
 |
UNIQURE N.V. | -1.2% |
|
ANAPTYSBIO, INC. | -1.2% |
|
ERASCA, INC. | -1.1% |
|
SUMMIT THERAPEUTICS INC | -1.1% |
|
IGM BIOSCIENCES, INC. | -1.1% |
|
DYNE THERAPEUTICS INC | -1.0% |
|
VERVE THERAPEUTICS, INC. | -1.0% |